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Abstract 
Background and purpose: As the 
postoperative recurrence of meningioma 
can have devastating effects, it is important 
to identify factors that can be used to 
predict this type of tumor recurrence. 
Material and methods: We have performed 
a retrospective study involving 138 patients 
who were surgically treated for intracranial 
meningioma between 2005 and 2010. The 
patient population consisted of 80 females 
and 58 males, with an age range of 23 to 77 
years old (mean age = 52 years). We 
measured associations between 
meningioma recurrence and clinical 
features (age, sex, extent of resection, 
histological type), or radiological features 
(tumor size, location, shape, calcification, 
bone changes, brain tumor interface, tumor 
necrosis, and MRI enhancement). 
Results: We found statistically higher 
levels of postoperative meningioma 
recurrence in patients with high Simpson 
grade resections, high histological types, 
tumor diameters > 5 cm, tumors located in 
the base of the skull or the parasagittal 
sinus, tumors with unclear border, irregular 
enhancements on MRI, edema around the 
tumor, bleeding and necrosis within the 
tumor, and irregularly shaped tumors (e.g., 
lobulated or mushroom-shaped). In 
addition, calcification, age, sex, bone 
change, and dural tail sign provided no 
predictive value. 
Conclusions: We have shown that 
histological type, degree of resection, 
bleeding, necrosis, edema, irregular 
enhancement, location, shape, size, and 
margin serve as strong predictors for the 
postoperative recurrence of meningioma 
tumors. 
Key words: factors, meningioma, 
neurosurgery, recurrence. 
Introduction 
Meningiomas can remain asymptomatic 
throughout a person’s life and are typically 
non-life-threatening because they exhibit 
little (less than 1 cm²) or no growth over 
many years. In a small number of cases, 
however, these kinds of tumors pose a real 
danger. This is particularly true during 
postoperative regrowth of a meningioma, 
which can cause devastating outcomes for 
the patient. Our study highlights factors 
that can be used to predict the recurrence of 
postoperative meningioma. 
Material and methods 
We collected data associated with 
patients who underwent meningioma 
resection at the Sun Yat Sen Memorial 
Hospital between 2005 and 2010. There 
were 138 patients, of which 58 (42%) were 
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male and 80 (58%) were female. Ages 
ranged from 23 to 77 years old, with a mean 
age of 52.13 years. We excluded patients 
with multiple intracranial tumors, severe 
organ failure, patients who underwent 
postoperative radiation therapy, and patients 
whose tumor-resection procedure received a 
Simpson grade of IV or V. The criteria we 
used to diagnose the recurrence of 
postoperative meningioma were radiological 
measurements (e.g., computed tomography 
(CT) scan, and magnetic resonance imaging 
(MRI)) and the recurrence of clinical 
symptoms after the remission period. To 
determine the relative risks of meningioma 
recurrence associated with fifteen 
independent variables we used the Chi 
Square Test (χ2 ) to perform binary logistic 
regression analysis. See Tables 1 and 2. 
 
TABLE 1 
Radiological predictors 
Predictor  Cases Percentage (%) 
Margin 
 
clear 
unclear 
128 
10 
92.8 
7.2 
Bone Changes 
 
(+) 
(–) 
35 
103 
25.4 
74.6 
Calcification 
 
(+) 
(–) 
25 
113 
18.1 
81.9 
Shape 
 
circular 
lobulated 
mushroom 
113 
17 
8 
81.9 
12.3 
5.8 
Dura Tail Sign (+) 
(–) 
61 
77 
44.2 
55.8 
T1 Enhancement regular 
irregular 
119 
19 
86.2 
13.8 
Necrosis 
 
(+) 
(–) 
9 
129 
6.5 
93.5 
Bleeding 
 
(+) 
(–) 
7 
131 
5.1 
94.9 
Edema 
 
(+) 
(–) 
34 
95 
31.2 
68.8 
Location 
 
parasagittal 
skull base 
other 
34 
47 
57 
24.6 
34.1 
41.3 
Size    ≤ 5 cm 
> 5 cm 
104 
34 
75.4 
24.6 
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TABLE 2 
Clinical predictors 
Predictor  Cases Percentage (%) 
Sex male 
female 
58 
80 
42.03 
57.97 
Age > 50 
≤ 50 
60 
78 
43.00 
57.00 
Resection Degree 
(Simpson) 
I 
II 
III 
77 
36 
25 
47.1 
31.2 
21.7 
Histological Type benign 
atypical 
malignant 
115 
13 
10 
87.0 
9.4 
3.6 
 
TABLE 3 
Results of comparing radiological factors 
Predictor  Patients 
With 
Recurrence   
Patients 
Without 
Recurrence 
Recurrence
Rate (%) 
χ2 P value 
Margin 
 
clear 
 
unclear 
12 
 
5 
116 
 
5 
9.4 
 
50.0 
 
14.172 
 
0.000 
Bone Change 
 
(+) 
 
(–) 
9 
 
8 
26 
 
95 
25.7 
 
7.8 
 
7.790 
 
0.05 
Calcification 
 
(+) 
 
(–) 
3 
 
14 
22 
 
99 
12.0 
 
12.4 
 
0.03 
 
0.957 
Shape 
 
circular 
 
lobulated 
 
mushroom 
8 
 
4 
 
5 
105 
 
13 
 
3 
7.1 
 
23.5 
 
62.5 
 
 
23.500 
 
 
 
 
0.000 
 
Dura Tail Sign (+) 
 
(–) 
6 
 
11 
55 
 
66 
9.8 
 
14.3 
 
0.624 
 
0.430 
T1 
Enhancement 
regular 
 
irregular 
7 
 
10 
112 
 
9 
5.9 
 
52.6 
 
33.151 
 
0.000 
Necrosis 
 
(+) 
 
(–) 
7 
 
10 
2 
 
119 
77.8 
 
7.8 
 
38.149 
 
0.000 
Bleeding (+) 
 
(–) 
5 
 
12 
2 
 
119 
71.4 
 
9.2 
 
23.835 
 
0.000 
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Edema 
 
(+) 
 
(–) 
13 
 
4 
30 
 
91 
30.2 
 
4.2 
 
18.557 
 
0.000 
Location 
 
skull base 
 
parasagittal 
 
other 
12 
 
5 
 
0 
35 
 
29 
 
57 
25.5 
 
14.7 
 
0.0 
 
 
15.784 
 
 
0.000 
Size    > 5 cm 
 
≤ 5 cm 
10 
 
7 
24 
 
97 
29.4 
 
6.7 
 
12.203 
 
0.000 
 
TABLE 4 
Result of comparing clinical factors 
Predictor  Patients 
with 
Recurrence 
Patients 
without 
Recurrence 
Recurrence 
Rate (%) 
χ2 P value 
Sex male 
female 
11 
6 
47 
74 
19.0 
7.5 
 
4.092 
 
0.043 
Age > 50 
≤ 50 
5 
12 
55 
66 
8.3 
15.4 
 
1.561 
 
0.212 
Resection 
Degree 
(Simpson) 
I 
II 
III 
1 
6 
10 
76 
30 
15 
1.3 
16.7 
40.0 
 
27.023 
 
0.000 
Histological 
Type 
benign 
atypical 
malignant 
5 
4 
8 
110 
9 
2 
4.3 
30.8 
80.8 
 
53.271 
 
0.000 
 
TABLE 5 
Binary logistic regression analysis 
Variable Influence Score                    P value 
Sex 4.092 0.043 
Age 0.849 0.381 
Calcification 0.003 0.957 
Bone Change 7.790 0.005 
Location 23.500 0.000 
Irregular Enhancement 33.151 0.000 
Edema 18.557 0.000 
Dural Tail Sign 0.624 0.430 
Shape 22.228 0.000 
Margin 14.172 0.000 
Necrosis 38.194 0.000 
Bleeding 23.853 0.000 
Size 12.203 0.000 
Resection Degree 27.023 0.000 
Histological Type 52.114 0.000 
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Results 
Seventeen patients had a recurrence of 
meningioma, resulting in a recurrence rate 
of 12.32%. Ten factors were significant 
predictors of recurrence, namely the degree 
of tumor resection, histological type, 
location, necrosis, bleeding, edema, shape, 
margin, irregular enhancement, and size (P 
< 0.05). For the factors sex and bone 
change, the significance of their predictive 
value was unclear (P = 0.043, and P = 0.05, 
respectively). Histological type, the extent 
of tumor resection, necrosis, bleeding, 
location, and irregular enhancement had 
strong effects on the postoperative 
recurrence of meningioma. See tables 3, 4, 
and 5. 
To illustrate one case, a 36-year-old male 
patient presented with a headache that had 
lasted 6 months and 3 days of vomiting. 
After being admitted to our department, 
head MRI revealed a 57 × 60 mm 
compressive cystic solid mass in the right 
temporal region with surrounding edema. 
Magnetic resonance spectroscopy results 
included a reduced N-acetyl aspartate 
(NAA) peak, an elevated choline (Cho) 
peak elevated, and a Cho/NAA ratio of 3.18, 
which suggested a malignant tumor in the 
right temporal lobe (Figure 1 a, b). The 
patient was subjected to a right temporal 
lobe lesionectomy. Results of the 
postoperative tumor biopsy were: anaplastic 
(malignant) meningioma, WHO grade III 
(Figure 2 C, D). Three months later the 
patient started to have a mild headache. A 
follow up head MRI T2, T1 + C indicated 
tumor recurrence (Figure 3 A, B). 
 
 
Figure 1 - (a) MRI revealed a 57 × 60 mm compressive cystic solid mass in the right temporal region with 
surrounding edema. (b) Magnetic resonance spectroscopy results included a reduced N-acetyl aspartate (NAA) 
peak, an elevated choline (Cho) peak, and a Cho/NAA ratio of 3.18, which suggested a malignant tumor in the 
right temporal lobe 
 
Figure 2 
Postoperative tumor biopsy revealed an anaplastic (malignant) meningioma, WHO grade III. loss of 
meningiomatous tissue and numerous typical and atypical mitoses 
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Figure 3 
Follow up head MRI T2, T1 + C indicated tumor recurrence 
 
Discussion 
Meningiomas are generally benign 
tumors that originate from the meninges, in 
particular cells of the arachnoid villi. These 
types of tumors represent ~15–20% of all 
intracranial tumors, with an annual 
incidence of ~2 per 100,000 within the 
general population. Likelihood of 
developing meningioma increases with age, 
as they commonly occur in the fourth to 
sixth decades of life. Females are twice as 
likely to be diagnosed with meningioma 
than males, which may result from the 
expression of female hormone receptors by 
meningioma tumors cells [4]. However this 
sex distribution does not characterize the 
pediatric population [6].  
As mentioned above, meningioma 
tumors are generally benign, but can recur 
after surgical resection. Our study shows 
that meningioma recurrence was 
significantly associated with a number of 
predictive factors, namely histological type, 
the degree of resection, location, edema, 
necrosis, bleeding, shape, size, 
enhancement pattern, and margin. Whether 
patient sex contributes to the recurrence of 
meningioma remains controversial, as some 
studies have shown that male patients tend 
to recur [9], whereas other studies have 
detected no relationship between sex and 
recurrence [11]. In our patient sample, the 
association between sex and recurrence 
yielded an ambiguous level of significance 
(P = 0.043). We conclude that sex may not 
influence the recurrence of meningioma. 
Patients in their fourth decade have a 
higher rate of recurrence than other age 
groups [18,20]. However, our study did not 
find that age was a significant factor in the 
recurrence of meningioma (P > 0.05). 
Concerning the radiological features of 
meningioma, we found that location plays 
the primary role in the recurrence of 
meningioma. Meningioma can be found in 
the base of the skull, the parasinuses, the 
intraventricule system, or on the convexity 
of the brain far from the sinuses. 
Meningiomas at the base of the skull and 
the parasagittal sinus are difficult to treat 
because these tumors adhere to 
neurovascular structures. This makes it 
difficult to perform zero or grade I Simpson 
resection, providing a chance for these 
tumors to recur after surgery. We have 
recommended, therefore, postoperative 
radiotherapy for residual tumor tissue 
within these areas [10]. 
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The skull bone often reacts to 
neighboring meningioma, and is sometimes 
invaded by tumor cells. Meningioma can 
cause hyperostosis or osteolysis to the 
nearby skull, and patients with osteolysis 
show higher recurrence rates than those 
with hyperostosis [19]. Here we divided 
our 138 patients into two groups, those 
with and without bone changes. We found 
no significant difference between these two 
groups (P = 0.05). 
Dural tail sign can be visualized using 
MRI with contrast agents like gadolinium-
diethylenetriaminepentacetate (Gd-DTPA), 
and can distinguish between meningiomas 
that are attached to the dura and other types 
of tumors. In 1990 Goldsher et al. [5] 
described dural tail sign as: (1) the presence 
of at least two consecutive sections through 
the tumor at the same site in more than one 
imaging plane, (2) greatest dural thickness 
adjacent to the tumor and tapering away 
from it, and (3) more intense enhancement 
of dural tissue than of the tumor itself. 
Furthermore, Goldsher et al. suggested that 
the presence of dural tail sign adjacent to a 
peripherally located mass is a highly specific 
sign of meningioma [5]. Tumor cells have 
been shown to invade the dural tail [15], 
although this is not always the case [23]. 
Previous studies have detected no 
correlations between dural tail sign and 
meningioma recurrence [13], which agrees 
with our current result (P = 0.430). 
In some rapidly growing forms of 
meningioma, like anaplastic meningioma, 
the insufficient supply of oxygen can cause 
necrosis. Areas of breakdown or bleeding 
inside a tumor that result from necrosis are 
characterized by irregular enhancement on 
MRI T1 Gd-DTPA. These irregular 
meningioma enhancements, as visualized 
by CT scans or MRI, have been associated 
with high rates of recurrence [2, 24]. 
Others have suggested that hypointense 
areas or irregular enhancements on CT 
scans or MRIs indicate malignant types of 
meningioma [3, 21]. Dietemann et al. 
found that for 4 of 5 patients with 
malignant meningioma, their CT/MRI 
scans revealed irregular enhancement [3]. 
Patients in our study that had necrosis, 
bleeding, or irregular MRI enhancements 
exhibited higher rates of recurrence than 
others groups (P < 0.05). 
We divided patients into three groups 
based on the shape of the meningioma: 
spherical, lobulated, and mushroom. There 
was a significant difference between these 
three groups (P < 0.05), as spherical, 
lobulated, and mushroom shapes had 
recurrence rates of 7.1%, 23.5%, and 62.5%, 
respectively. Previous studies have also 
shown that mushroom-shaped 
meningiomas exhibit very malignant 
behavior [1, 7, 16]. 
Most studies have shown that the 
presence of intratumoral calcification 
indicates a low rate of tumor recurrence. In 
fact, levels of calcification and the 
histological type of the tumor are closely 
correlated [14]. We have noticed that 
benign meningioma tumors are generally 
calcified compared with malignant ones. In 
addition, calcified meningiomas have low 
rates of recurrence [14]. Our data show that 
calcification was not able to predict 
meningioma recurrence (P > 0.05), but it 
can be use to differentiate between benign 
and malignant tumors. 
We also divided patients into two groups 
based on meningioma size: ≤ 5 cm or > 5 
cm. Although some studies have suggested 
that large-diameter tumors are more likely 
to recur [13], we found no significant 
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difference between these two groups (P   
0.05).  
The incidence of edema around 
meningioma is ~60% [17]. Peritumoral 
edema promotes tumor-cell invasion of 
brain parenchyma, making it more difficult 
to surgically remove all the tumor cells and 
increasing the likelihood of recurrence 
[12]. For patients in our study group the 
presence of moderate or severe edema 
resulted in higher rates of recurrence (P < 
0.05). 
Clinical care providers are fully aware 
that meningioma recurrence is related to 
the extent of resection. As such, the 
Simpson grading system is used around the 
world [22]. We have found it difficult to 
perform grade zero or I resections for 
tumors: 1) located at the base of the skull, 
2) that were invading sinuses, or 3) with 
unclear margins (particularly tumors with 
irregular shapes). Our study indicated that 
higher Simpson grades are associated with 
higher rates of recurrence. 
Finally, we divided meningioma patients 
into three groups according to world health 
organization (WHO) histological 
classifications: benign (I), atypical (II), and 
malignant (III). Recurrence rates associated 
with groups I, II, and III were 4.3%, 30.8%, 
80.0%, respectively, which represented 
significant differences (P < 0.05). This 
agrees with a previous report that measured 
five-years recurrence rates after 
meningioma resection of 3%, 38%, and 78% 
for grades I, II, and III, respectively [8]. 
Conclusions 
We have shown that degree of tumor 
resection, histological type, pattern of 
enhancement, necrosis and bleeding within 
the tumor, peritumoral edema, tumor size, 
margin characteristics, shape, and location 
are important factors for predicting the 
postoperative recurrence of meningioma 
tumors. 
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